Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

Wegovy, like Ozempic, is a brand name for semaglutide and offered to people via prescription when they're having issues with ...

Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half ...

The syringe option is cheaper for consumers: It costs between $349 and $699 a month for the vials compared to a list price of ...

Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

The cash-pay offering is available to millions of patients without insurance coverage for the blockbuster injection. It aims to make Wegovy available to more people, while also ensuring that ...